Fatty acid regulation of very low density lipoprotein production

Current Opinion in Lipidology

Volumn 8, Issue 3, 1997, Pages 146-153

  Lewis, Gary F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ESTERIFICATION; FATTY ACID BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOGENESIS; LIPOLYSIS; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER CELL; LIVER METABOLISM; NONHUMAN; NUTRITIONAL STATUS; OXIDATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW;

ANIMALS; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; HOMEOSTASIS; HUMANS; LIPOPROTEINS, VLDL; LIVER; MODELS, BIOLOGICAL; TRIGLYCERIDES;

EID: 0030798890     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199706000-00004     Document Type: Review

References (59)

1. Ginsberg HN: Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr Opin Lipidol 1995, 6:275-280.
2. Sparks JD, Sparks CE: Insulin regulation of triacylglycerol-rich lipo-protein synthesis and secretion [Review]. Biochim Biophys Acta 1994, 1215:9-32.
3. Brett DJ, Pease RJ, Scott J, Gibbons GF: Microsomal triglyceride transfer protein activity remains unchanged in rat livers under conditions of altered very-low-density lipoprotein secretion. Biochem J 1995, 310:11-14.
4. Lin MC, Gordon D, Wetterau JR: Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 1995, 36:1073-1081.
5. Fast DG, Vance DE: Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evid-ence for a novel mechanism that regulates VLDL secretion. Biochim Biophys Acta 1995, 1258:159-168.
6. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, Gregg RE: Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 258:999-1001.
7. Gibbons GF, Bartlett SM, Sparks CE, Sparks JD: Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem J 1992, 287:749-753.
8. Gibbons GF, Wiggins D: Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). Adv Enzyme Regul 1995, 35:179-198. A comprehensive review of a series of experiments performed by these investigators, designed to examine the intracellular trafficking of fatty acids and triglycerides, and the incorporation of triglycerides into the core of newly synthesized lipoproteins in the liver. The authors discuss how intracellular compartmentation of fatty acids contributes to the regulation of hepatic ketogenesis and triglyceride secretion.
9. Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD: Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res 1990, 31:2045-2055.
10. 100 without previous hydrolysis/re-esterification
11. Musanti R, Giorgini L, Lovisolo P, Pirillo A, Chiari A, Ghiselli G: Inhibition of acyl-CoA : cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. J Lipid Res 1996, 37:1-14.
12. Huff MW, Telford DE, Barrett PH, Billheimer JT, Gillies PJ: Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler Thromb 1994, 14:1498-1508.
13. Carr TP, Hamilton RL Jr, Rudel LL: ACAT Inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J Lipid Res 1995, 36:25-36.
14. Wu X, Sakata N, Lui E, Ginsberg HN: Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J Biol Chem 1994, 269:12375-12382.
15. Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK: Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 1995, 96:2735-2743. This is one of the few studies to attempt to quantitate the contribution of de-novo lipogenesis as a fraction of total hepatic triglyceride fatty acid production in humans. These investigators have shown, using an innovative stable isotope-labelling technique, that carbohydrate feeding stimulates de-novo lipogenesis by approximately 10-fold and spares lipid oxidation; nevertheless absolute hepatic de-novo lipogenesis still accounts for less than 5 g of fatty acids synthesized each day.
16. Sniderman AD, Cianflone K: Substrate delivery as a determinant of hepatic apoB secretion [Review]. Arterioscler Thromb 1993, 13:629-636.
17. Kempen HJ, Imbach AP, Giller T, Neumann WJ, Hennes U, Nakada N: Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors. J Lipid Res 1995, 36:1796-1806. Glucose added to the medium of HepG2 cells increased apoB secretion by inhibiting its intracellular degradation. The stimulatory effects of glucose and oleate on apoB secretion by HepG2 cells was shown to be additive, suggesting that apoB secretion is greatly enhanced when both the internal (via lipogenesis from glucose) and external supply of fatty acids is increased.
18. Duerden JM, Gibbons GF: Secretion and storage of newly synthesized hepatic thacylglycerol fatty acids in vivo in different nutritional states and in diabetes. Biochem J 1988, 255:929-935.
19. Gibbons GF, Burnham FJ: Effect of nutritional state on the utilization of fatty acids for hepatitic triacylglycerol synthesis and secretion as very-low-density lipoprotein. Biochem J 1991, 275:87-92.
20. Wiggins D, Hems R, Gibbons GF: Decreased sensitivity to the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultured hepatocytes from fructose-fed rats. Metabolism 1995, 44:841-847.
21. Bourgeois CS, Wiggins D, Hems R, Gibbons GF: VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin. Am J Physiol 1995, 269:E208-E215.
22. Bourgeois CS, Wiggins D, Gibbons GF: Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes. Biochem J 1996, 314:103-108.
23. Hellerstein MK, Christiansen M, Kaempfer S, Kletke C, Wu K, Reid JS, Mulligan K, Hellerstein NS, Shackleton CH: Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 1991, 87:1841-1852.
24. Aarsland A, Chinkes D, Wolfe RR: Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia hyperinsulinemia in normal man. J Clin Invest 1996, 98: 2008-2017. Four days of carbohydrate hyperalimentation/hyperinsulinemia in healthy men increased the VLDL-triglyceride secretion rate 3.4-fold. The 2.7-fold increase in secretion rate of preformed fatty acid contributed quantitatively the most to the total VLDL-triglyceride secretion rate, even though de-novo lipogenesis increased greatly.
25. Wiggins D, Gibbons GF: The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. Biochem J 1992, 284:457-462.
26. Yang LY, Kuksis A, Myher JJ, Steiner G: Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. J Lipid Res 1995, 36:125-136.
27. 6]ethanol. J Lipid Res 1996, 37:262-274. Using different methodology to that used above [25], these authors reached similar conclusions to Wiggins and Gibbons, with a very similar estimate of the proportion of secreted triglyceride derived from hydrolysis of intracellular triglyceride stores (about 60%).
28. Wu X, Sakata N, Dixon J, Ginsberg HN: Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and posttranslational mechanisms. J Lipid Res 1994, 35:1200-1210. These experiments incubating VLDL with HepG2 cells showed that it is the increase in intracellular triglyceride and not cholesteryl ester that is the critical factor associated with a stimulation of apoB secretion. In addition to the expected posttranslational effects, VLDL also regulated apoB secretion at the pretranslational level.
29. Craig WY, Cooper AD: Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells. J Lipid Res 1988, 29:299-308.
30. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild DE, Brito AE, Scott J: The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 1989, 30:1065-1077.
31. Byrne CD, Brindle NP, Wang TW, Hales CN: Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J 1991, 280:99-104.
32. Byrne CD, Wang TW, Hales CN: Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J 1992, 288:101-107.
33. Levinson M, Oswald B, Quarfordt S: Serum factors influencing cultured hepatocyte exogenous and endogenous triglyceride. Am J Physiol 1990, 259:G15-G20.
34. Dixon JL, Furukawa S, Ginsberg HN: Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibi-ting early intracellular degradation of apolipoprotein B. J Biol Chem 1991, 266:5080-5086.
35. White AL, Graham DL, Legros J, Pease RJ, Scott J: Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. J Biol Chem 1992, 267:15657-15664.
36. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G: Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995, 95:158-166. Insulin was shown in humans to acutely inhibit VLDL-apoB and VLDL-triglyceride production (by about 50%). partly by the acute suppression of plasma FFAs and partly by a non-FFA mediated (probably direct hepatic) effect. An acute elevation of FFAs stimulated VLDL-triglyceride and VLDL-apoB production.
37. Bjornsson OG, Duerden JM, Bartlett SM, Sparks JD, Sparks CE, Gibbons GF: The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects. Biochem J 1992, 281:381-386.
38. Furukawa S, Sakata N, Ginsberg HN, Dixon JL: Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells. J Biol Chem 1992, 267:22630-22638.
39. Sakata N, Wu X, Dixon JL, Ginsberg HN: Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells. J Biol Chem 1993, 268:22967-22970.
40. Wang H, Chen X, Fisher EA: N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J Clin Invest 1993, 91:1380-1389.
41. Lewis GF, Steiner G: Acute effects of insulin in the control of VLDL production in humans. Diabetes Care 1996, 19:390-393.
42. Steiner G, Lewis GF: Hyperinsulinemia and triglyceride-rich lipoproteins. Diabetes 1996, 45(suppl 3):S24-S26.
43. Lewis GF, Uffelman KD, Szeto LW, Steiner G: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993, 42:833-842.
44. Dashti N, Wolfbauer G: Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res 1987, 28:423-436.
45. Patsch W, Gotto AM Jr, Patsch Jr: Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem 1986, 261:9603-9606.
46. Sparks JD, Sparks CE: Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion. Biochem Biophys Res Commun 1994, 205:417-422.
47. Steiner G, Haynes FJ, Yoshino G, Vranic M: Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am J Physiol 1984, 246:E187-E192.
48. Duerden JM, Bartlett SM, Gibbons GF: Long-term maintenance of high rates of very-low-denslty-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of Insulin and insulin deficiency in vitro. Biochem J 1989, 263:937-943.
49. Duerden JM, Bartlett SM, Gibbons GF: Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals. Biochem J 1989, 262:313-319.
50. Salam WH, Wilcox HG, Heimberg M: Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver. Biochem J 1988, 251:809-816.
51. Kazumi T, Vranic M, Steiner G: Triglyceride kinetics: effects of dietary glucose, sucrose, or fructose alone or with hyperinsulinemia. Am J Physiol 1986, 250:E325-E330.
52. Park OJ, Cesar D, Faix D, Wu K, Shackleton CH, Hellerstein MK: Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J 1992, 282:753-757.
53. Boden G, Chen X, Desantis RA, Kendrick Z: Effects of insulin on fatty acid reesterification in healthy subjects. Diabetes 1993, 42:1588-1593.
54. Groop LC, Bonadonna RC, Delprato S, Ratheiser K, Zyck K, Ferrannini E, Defronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989, 84:205-213.
55. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS: Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991, 72:934-944.
56. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk ML, Potts JL, Hockaday TD: Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992, 41:264-72.
57. Roust LR, Jensen MD: Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 1993, 42:1567-1573.
58. Lewis GF, O'Meara NM, Cabana VG, Blackman JD, Pugh WL, Druetzler AF, Lukens JR, Getz GS, Polonsky KS: Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement. Diabetologia 1991, 34:253-259.
59. Baldo A, Sniderman AD, St-Iuce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K: The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993, 92:1543-1547.